A detailed history of Exodus Point Capital Management, LP transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 21,119 shares of LRMR stock, worth $131,571. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,119
Holding current value
$131,571
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.3 - $10.68 $133,049 - $225,550
21,119 New
21,119 $138,000
Q2 2021

Aug 16, 2021

SELL
$8.0 - $15.2 $293,056 - $556,806
-36,632 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$14.61 - $22.19 $332,728 - $505,355
-22,774 Reduced 38.34%
36,632 $535,000
Q4 2020

Feb 16, 2021

BUY
$14.28 - $25.06 $848,317 - $1.49 Million
59,406 New
59,406 $1.27 Million

Others Institutions Holding LRMR

About Larimar Therapeutics, Inc.


  • Ticker LRMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,269,200
  • Market Cap $270M
  • Description
  • Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...
More about LRMR
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.